中文
| Catalogue |
|
|
| Recommend Products |
Kupando GmbH
Germany, Manufacturer, Hits: 20, Updated:8/6/2026
Willy-Brandt-Platz 2 12529 Sch?nefeld Germany |
Company Profile
-
KUPANDO is a pioneering biotech company focused on developing innovative therapies to address critical unmet medical needs in cancer and infectious diseases. Its disruptive approach harnesses the power of innate immune stimulation and induction of trained innate immunity by dual Toll-Like Receptor (TLR) agonists. This unique modality underpins the Company’s pipeline of first-in-class, differentiated small molecules with the potential to transform the management of these challenging diseases. Its lead candidate, KUP101, is a differentiated dual TLR 4 and 7 agonist in Phase 1 clinical study in advanced skin tumors.
Kupando is headquartered in Sch?nefeld, Germany and is backed by specialist institutional investors including Remiges Ventures, LifeCarePartners, Brandenburg Kapital, High-Tech Gründerfonds, Ventura Biomed Investors, Carma Fund Management and undisclosed family offices.